`Paper 32
`Entered June 26, 2020
`Entered June 26, 2020
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS INC,
`Petitioner,
`
`V.
`
`MERCK SHARP & DOHME CORR,
`Patent Owner.
`
`Case No. lPR2020—00040
`
`U.S. Patent No. 7,326,708
`
`JOINT NOTICE OF STIPULATION TO ADJUST SCHEDULE AND
`[MD] ORDER
`
`72m
`
`
`
`
`
`Case No. IPR2020—00040
`
`U.S. Patent No. 7,326,708
`
`Pursuant to the email from the Board on June 9, 2020, in which the Board
`
`instructed the Parties to file a stipulation and proposed order to memorialize
`
`requested changes to the Scheduling Order, Patent Owner Merck Sharp & Dohme
`
`Corp. and Petitioner Mylan Pharmaceuticals Inc. hereby notify the Board that they
`
`have stipulated to the requested changes to the Scheduling Order set forth below.
`
`The Parties note that the following adjusted schedule only reflects stipulated
`
`changes to the portion of Due Date 2 related to Petitioner’s opposition to a motion
`
`to amend and the portion of Due Date 3 related to Patent Owner’s reply to an
`
`opposition to a motion to amend. The remaining dates remain unchanged. In the
`
`Board’s email dated June 9, 2020, the Board preliminarily approved the following
`
`changes to the schedule:
`
`Due Date No.
`
`
`
`Current Due Date1
`
`
`
`Due Date 2(b)3
`
`Due Date 3(a)4
`
`December 9, 2020
`
`
`
`
`October 28, 2020
`Due Date 2(a)2
`
`
`
`
`
`
`November 6, 2020
`
`
`
`
`
`
`
`Sti n uiated Due Date
`
`November 6, 2020
`
`
`
`
`
`
`December 18, 2020
`
`
`
`' The Current Due Dates column reflects the changes previously stipulated to by
`the Parties (Paper 30) for Due Dates 1, 2(b) and 3(b) pursuant to the authorization
`provided in the Scheduling Order (Paper 22, at 7).
`3 Due Date 2(a) refers to the portion of Due Date 2 related to Petitioner’s
`opposition to a motion to amend.
`3 Due Date 2(b) refers to the portion of Due Date 2 related to Petitioner’s reply.
`
`
`
`
`
`T“... ...... an ”H'Y'F1
`
`Case No. IPR2020—00040
`
`US. Patent No. 7,326,708
`
`
`
`Due Date 303)5 December 18, 2020
`
`Due Date 4
`
`December 30, 2020
`
`
`
`Case No. IPR2020—00040
`
`U.S. Patent No. 7,326,708
`
`Counselfor Patent Owner
`Merck Sharp & Dohme Corp.
`
`/Jitendra Malik/
`
`Jitendra Malik, PhD. (Reg. No. 55,823)
`Alissa M. Pacchioli (Reg. No. 74,252)
`Christopher D. West, PhD. (Reg. No.
`74,724)
`Heike S. Radeke, PhD. (Reg. No.
`
`75,394)
`KATTEN MUCHIN ROSENMAN
`
`550 S. Tryon Street, Suite 2900
`Charlotte, NC 28202-4213
`jitty.malik@kattenlaw.com
`a]issa.pacchioli@katten.com
`christopher.west@katten.com
`heike.radeke@katten.com
`Counsel for Petitioner
`
`Mylan Pharmaceuticals Inc
`
`Counsel for Petitioner
`fi/[ylcm Pharmaceuticals Inc.
`
`
`
`
`
`Case No. IPR2020-00040
`
`US. Patent No. 7,326,708
`
`[W] ORDER
`
`many
`
`Conduct of the Proceeding
`
`Pursuant to an agreement and stipulation between the parties, and further to
`
`the email from the Board on June 9, 2020, in which the Board instructed the parties
`
`to file a stipulation and proposed order to memorialize the aforementioned
`
`agreement, the Board is aware that the parties have stipulated to the following
`
`changes to the Scheduling Order:
`
`Current Due Date1
`
`Stiulated Due Date
`
`Due Date 2(a)2
`
`Due Date 2(b)3
`
`November 6, 2020
`
`
`
`
`
`
`
`
`
`
`
`unchanged
`October 28, 2020
`November 6, 2020
`
`Due Date 3(a)“
`December 9, 2020
`December 18, 2020
`
`
`
`
`December 18, 2020
`Due Date 3(b)56
`
`
`
`
`Due Date 4
`December 30, 2020
`unchanged
`
`January 20, 2021 unchanged
`
`Due Date 5
`
`unchanged
`
`
`
`1 The Current Due Dates column reflects the changes previously stipulated to by
`the Parties (Paper 30) for Due Dates 1, 2(b) and 3(b) pursuant to the authorization
`provided in the Scheduling Order (Paper 22, at 7).
`2 Due Date 2(a) refers to the portion of Due Date 2 related to Petitioner’s
`opposition to a motion to amend.
`3 Due Date 2(b) refers to the portion of Due Date 2 related to Petitioner’s reply.
`4 Due Date 3(a) refers to the portion of Due Date 3 related to Patent Owner’s
`reply to an opposition to a motion to amend.
`5 Due Date 3(b) refers to the portion of Due Date 3 related to Patent Owner’s sur-
`reply.
`
`
`
`
`
`
`
`Case No. 1PR2020-00040
`
`US. Patent No. 7,326,708
`
`
`
`January 27, 2021 Due Date 6 unchanged ‘
`
`
`
`
`Due Date 7
`February 3, 2021
`
`
`
`unchanged
`
`In consideration of the foregoing, it is hereby:
`
`ORDERED that the Parties" requested Changes are granted and the Parties
`
`are to adhere to the below REVISED DUE DATE APPENDIX.
`
`
`
`
`
`Case No. 1PR2020—00040
`
`US. Patent No. 7,326,708
`
`REVISED DUE DATE APPENDIX
`
`DUE DATE 1 .......................................................................... August 14, 2020
`
`Patent Owner‘s response to the petition
`Patent Owner’s motion to amend the patent
`
`DUE DATE 2 ...................................................................... November 6, 2020
`
`Petitioner’s reply to Patent Owner’s response to petition
`Petitioner’s opposition to motion to amend
`
`DUE DATE 3 ..................................................................... December 18, 2020
`
`Patent Owner’s sur-reply to reply
`Patent Owner’s reply to opposition to motion to amend (or Patent Owner’s
`revised motion to amend)
`
`DUE DATE 4 ................................................................... December 30, 2020
`
`Request for oral argument (may not be extended by stipulation)
`
`DUE DATE 5 ....................................................................... January 20, 2021
`
`Petitioner’s sur-reply to reply to opposition to motion to amend
`Motion to exclude evidence
`
`DUE DATE 6 ....................................................................... January 27, 2021
`
`Opposition to motion to exclude
`Request for prehearing conference
`
`DUE DATE 7 ....................................................................... February 3, 2021
`
`Reply to opposition to motion to exclude
`
`DUE DATE 8 ..................................................................... February 1 l, 2021
`
`Oral argument (if requested)
`
`
`
`
`
`Case No. lPR2020-00040
`
`US. Patent No. 7,326,708
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C .F .R. § 42.6(e), the undersigned hereby certifies that a true
`
`and correct copy ofthe foregoing was served on June 12, 2020, by delivering a
`
`copy via electronic mail on the following attorneys of record:
`
`J itendra Malik
`
`Alissa M. Pacchioli
`
`Christopher W. West
`Heike S. Radeke
`
`KATTEN MUCHIN ROSEMAN LLP
`
`550 South Tryon, Street Suite 2900
`Charlotte, NC 28202-4213
`
`(704) 444-2000
`jitty.malik@kattenlaw.com
`a1issa.pacchioli@katten.com
`christopher.west@katten.com
`heike.radeke@katten.com
`
`/Shaun. P. Mahaffg/
`Shaun P. Mahaffy
`Reg. No. 75,534
`
`
`
`